PD-1 INHIBITOR
Clinical trials for PD-1 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITOR trials appear
Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to zap tumors, save kidneys
Disease control Recruiting nowThis study is testing whether a combination of two drugs, tislelizumab and nab-paclitaxel, can effectively treat a type of kidney cancer located in the renal pelvis. The main goal is to control the cancer for at least one year while avoiding the need to surgically remove the enti…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists try to 'heat up' cold pancreatic tumors with radiation and immunotherapy combo
Disease control Recruiting nowThis study is testing whether a low dose of radiation can help turn a patient's immune system against their pancreatic cancer, making it more responsive to a new immunotherapy drug. It combines this radiation with the drug and standard chemotherapy. The goal is to see if this thr…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC